Human milk contains the essential fatty acids linoleic acid (18:2n-6) and ␣ -linolenic acid (18:3n-3) and their respective n-3 and n-6 long-chain polyunsaturated fatty acid (LCPUFA) metabolites. Arachidonic acid (20:4n-6; ARA) and docosahexaenoic acid (22:6n-3; DHA) are the most abundant LCPUFA in human milk ( 1 ). DHA and ARA accumulate in brain and retina at a high rate during the last trimester of pregnancy and the fi rst months of life ( 2 ). DHA and ARA may be synthesized in the body from the precursor essential fatty acids, ␣ -linolenic acid (18:3n-3; ALA) and linoleic acid (18:2n-6; LA), respectively. However, the endogenous conversion effi ciency of these precursor fatty Plasma oxylipin concentrations and free plasma PUFA levels were determined at day 28 using LC-MS/MS. Incremental dietary ARA intake dosedependently increased plasma ARA levels. In parallel, ARA intake dose-dependently increased ARA-derived diols 5,6-and 14,15-dihydroxyeicosatrienoic acid (DiHETrE) and linoleic acid-derived 12,13-dihydroxyoctadecenoic acid (DiHOME), downstream metabolites of cytochrome P450 expoxygenase (CYP). The ARA epoxide products from CYP are important in vascular homeostatic maintenance. Incremental DHA intake increased plasma DHA and most markedly raised the eicosapentaenoic acid (EPA) metabolite 17,18-dihydroxyeicosatetraenoic acid (DiHETE) and the DHA metabolite 19,20-dihydroxydocosapentaenoic acid (DiHDPE). In conclusion, increasing ARA and DHA intake dose-dependently infl uenced endogenous n-6 and n-3 oxylipin plasma concentrations in growing piglets, although the biological relevance of these fi ndings remains to be determined. -Bruins, M.